Consulting in the fields of:Biotech opportunity analysis for investment of unlisted and listed life sciences. Biopharmaceuticals, vaccines and delivery technologies for Human and Animal Health. Strengths: Taking R&D projects from discovery phase to market in vaccines (4 products), biopharma and diagnostics (2 products) with a track record in innovation, team and project leadership and DELIVERING. I have 35 years broad experience in leading and managing R&D stages, plus scale-up transfer to manufacturing and global tech-transfer. 4 products launched to global markets demonstrates an ability to lead and enthuse project teams to deliver commercial goals. Management experience leading and motivating R&D teams in both academic and commercial settings, resulting in multiple patents and first to market innovative products. Over 20 years experience in new opportunity evaluation and IP strategy with 5 years in investment analysis of small and micro cap biotechs.Expertise in:Scientific and commercial/investment evaluation of new technologies and product opportunities. Strategic planning for new opportunity adoptionR&D Portfolio planning.Vaccines: formulation, immunomodulator / adjuvant selection, delivery technologiesBiopharma approaches for non-infectious targets. Peptide vaccinesDelivery/slow release of biologicals